Pediatric Cancer Research From Past Successes Through Collaboration to Future Transdisciplinary Research
- 1 May 2004
- journal article
- review article
- Published by SAGE Publications in Journal of Pediatric Oncology Nursing
- Vol. 21 (3), 123-127
- https://doi.org/10.1177/1043454204264406
Abstract
Multidisciplinary collaboration in therapeutic research in childhood cancer has been responsible for enormous improvements in outcomes. Many of the improvements have resulted from large clinical trials carried out in multisite settings through the Children’s Oncology Group (COG) and its predecessors, the Children’s Cancer Group, the Pediatric Oncology Group, the National Wilms’ Tumor Study, and Intergroup Rhabdomyosarcoma Study Groups. Childhood acute lymphoblastic leukemia models the past success of 35 years of randomized clinical trials that resulted in survival rates of around 80%. However, more can be done to improve both survival rates and the quality of survival. Areas that can benefit from a transdisciplinary model of research are discussed, as well as challenges to this form of collaboration.Keywords
This publication has 15 references indexed in Scilit:
- Psychological Research in Childhood Cancer: The Children’s Oncology Group PerspectiveJournal of Pediatric Psychology, 2005
- Education, employment, insurance, and marital status among 694 survivors of pediatric lower extremity bone tumorsCancer, 2003
- The value of the PedsQLTM in assessing quality of life in survivors of childhood cancerChild: Care, Health and Development, 2003
- Pediatric oncology: current views and outcomesPediatric Clinics of North America, 2002
- Molecular genetic diagnosis of pediatric cancer: current and emerging methodsPediatric Clinics of North America, 2002
- Prediction of central nervous system embryonal tumour outcome based on gene expressionNature, 2002
- PATHWAYS OF APOPTOSIS AND THE MODULATION OF CELL DEATH IN CANCERHematology/Oncology Clinics of North America, 2001
- EXLOITING GENETIC ALTERATIONS TO DESIGN NOVEL THERAPIES FOR CANCERHematology/Oncology Clinics of North America, 2001
- Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia ChromosomeNew England Journal of Medicine, 2001
- Death Receptors: Signaling and ModulationScience, 1998